Mavacamten Derivatives Significantly Ameliorate Lipopolysaccharide-Induced Acute Lung Injury, Partly by Modulating Nuclear Factor Kappa‑B Signaling.

Mavacamten 衍生物显著改善脂多糖诱导的急性肺损伤，部分原因是通过调节核因子 Kappa-B 信号传导。